TELA Bio Profit Margin

The latest profit margin for TELA is -53.57% as of September 2026. That compares with -50.61% in the prior-year period — down 5.8% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside TELA Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, TELA's profit margin moved from -50.61% to -53.57% — a 5.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TELA Bio's valuation or profitability profile.

Against Healthcare companies, TELA currently prints -53.57% for profit margin, while the sector average sits near 17.63%. That is roughly 403.9% below the sector mean. Large gaps often invite a closer look at TELA Bio's growth, margins, and balance sheet.

Profit Margin shows how effectively TELA Bio converts resources into returns. At -53.57%, TELA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -50.61% in the prior-year period — down 5.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TELA's profit margin (-53.57%), review year-over-year change from -50.61%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.